| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |